SEC
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
SEC Investigating Illumina Over Grail Acquisition
Illumina said the SEC has requested documents, including records "related to the conduct and compensation of certain members of Illumina and Grail management."
Co-Diagnostics Fined $250K Over COVID-19 Claims, Undisclosed Hiring of Relatives
The firm settled with the US Securities and Exchange Commission without admitting or denying the allegations over public statements and hiring disclosures.
Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit
Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test.
CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC
The molecular diagnostics company reported $75.6 million in revenues for the quarter and said testing service revenues rose 46 percent year over year.
Sep 2, 2021
Cue Health Files for IPO for up to $100M
Mar 31, 2021
Talis Biomedical 2020 Revenues Rise Sharply
Nov 13, 2020
Abbott Enters $5B Credit Agreement
Sep 11, 2020
Hologic Raises Q4 Revenue Guidance
Sep 9, 2020
Early Cancer Detection Firm Grail Files for IPO
Jun 16, 2020
Progenity Eyes $122.6M in Amended IPO
Jun 15, 2020
Genetron Health Targeting $175.5M in Amended US IPO
Jun 7, 2020
ArcherDx Targeting $100M in IPO
Feb 12, 2020
OpGen Preliminary 2019 Revenues up 19 Percent
Dec 17, 2019
Grail Raises $125M in Equity Financing Offering
Nov 25, 2019